Tokyo Tape
Sign in
← Nissan Chemical Corporatiom

Quarterly report · Q3

4021.TEDINET S100Q6HC
Period2022-04-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥159.2bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥208.0bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥141.3bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥38.8bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥33.9bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥41.3bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥53.7bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥35.8bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥41.3bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥36.0bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥30.8bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥38.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥25.6bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥31.0bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥25.9bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥276.6bnat 2022-12-31Cons.Assets
Total assets¥279.7bnat 2022-03-31Cons.Assets
Total assets¥254.7bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥60.4bnat 2022-12-31Cons.Liabilities
Total liabilities¥71.7bnat 2022-03-31Cons.Liabilities
Net assets / equity¥216.2bnat 2022-12-31Cons.Net assets
Net assets / equity¥208.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥199.4bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥25.9bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥34.7bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥25.9bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥34.7bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥25.2bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥32.4bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥37.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥41.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥35.0bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥13.5bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥12.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥6.8bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥37.5bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥27.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥35.5bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥217.992022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥50.212022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥271.882021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥179.582021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥65.512021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio77.1%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.5%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 64
SegmentItemPeriodValue
Otherother segmentsrevenue2022-04-01 → 2022-12-31¥19.1bn
Otherother segmentsrevenue external2022-04-01 → 2022-12-31¥8.2bn
Otherother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥11.0bn
Otherother segmentssegment profit2022-04-01 → 2022-12-31¥343m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥80.6bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-12-31−¥22.3bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥58.3bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥4.1bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥48.8bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥40.4bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥8.4bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥15.2bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥29.9bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.5bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥9.4bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentrevenue2022-04-01 → 2022-12-31¥62.6bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentrevenue external2022-04-01 → 2022-12-31¥50.6bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥12.0bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentsegment profit2022-04-01 → 2022-12-31¥20.8bn
jpcrp040300-q3r_E00759-000Medicinesreportable segmentrevenue2022-04-01 → 2022-12-31¥4.8bn
jpcrp040300-q3r_E00759-000Medicinesreportable segmentrevenue external2022-04-01 → 2022-12-31¥4.8bn
jpcrp040300-q3r_E00759-000Medicinesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥10m
jpcrp040300-q3r_E00759-000Medicinesreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.1bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentrevenue2022-04-01 → 2022-12-31¥74.7bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentrevenue external2022-04-01 → 2022-12-31¥57.1bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥17.6bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentsegment profit2022-04-01 → 2022-12-31¥2.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥239.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥181.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥58.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥42.9bn
Otherother segmentsrevenue2021-04-01 → 2021-12-31¥16.5bn
Otherother segmentsrevenue external2021-04-01 → 2021-12-31¥7.1bn
Otherother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥9.4bn
Otherother segmentssegment profit2021-04-01 → 2021-12-31¥193m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥64.0bn
Reconciling Itemsreconcilingrevenue external2021-04-01 → 2021-12-31−¥16.4bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥47.6bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥3.8bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥36.9bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥32.0bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥4.9bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥9.9bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥27.6bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥19.1bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥8.5bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥2.5bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentrevenue2021-04-01 → 2021-12-31¥60.5bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentrevenue external2021-04-01 → 2021-12-31¥51.5bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥9.0bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentsegment profit2021-04-01 → 2021-12-31¥20.7bn
jpcrp040300-q3r_E00759-000Medicinesreportable segmentrevenue2021-04-01 → 2021-12-31¥5.3bn
jpcrp040300-q3r_E00759-000Medicinesreportable segmentrevenue external2021-04-01 → 2021-12-31¥5.2bn
jpcrp040300-q3r_E00759-000Medicinesreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥35m
jpcrp040300-q3r_E00759-000Medicinesreportable segmentsegment profit2021-04-01 → 2021-12-31¥2.3bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentrevenue2021-04-01 → 2021-12-31¥58.6bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentrevenue external2021-04-01 → 2021-12-31¥42.8bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥15.8bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentsegment profit2021-04-01 → 2021-12-31¥2.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥205.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥157.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥47.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥37.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 529
ItemContextValueUnit
Income taxes payableCurrentQuarterInstant3096000000JPY
Provision for bonusesPrior1YearInstant2285000000JPY
Provision for bonusesCurrentQuarterInstant750000000JPY
Other clPrior1YearInstant14398000000JPY
Other clCurrentQuarterInstant17423000000JPY
Current liabilitiesPrior1YearInstant65971000000JPY
Current liabilitiesCurrentQuarterInstant54878000000JPY
Long term loans payablePrior1YearInstant1182000000JPY
Long term loans payableCurrentQuarterInstant948000000JPY
Deferred tax liabilitiesPrior1YearInstant69000000JPY
Deferred tax liabilitiesCurrentQuarterInstant405000000JPY
Provision for business structure improvement nclPrior1YearInstant698000000JPY
Provision for business structure improvement nclCurrentQuarterInstant436000000JPY
Provision for loss on business of subsidiaries and affiliates nclPrior1YearInstant626000000JPY
Provision for loss on business of subsidiaries and affiliates nclCurrentQuarterInstant626000000JPY
Provision for share based remuneration for directors and other officers nclPrior1YearInstant200000000JPY
Provision for share based remuneration for directors and other officers nclCurrentQuarterInstant170000000JPY
Net defined benefit liabilityPrior1YearInstant290000000JPY
Net defined benefit liabilityCurrentQuarterInstant380000000JPY
Other nclPrior1YearInstant2638000000JPY
Other nclCurrentQuarterInstant2521000000JPY
Noncurrent liabilitiesPrior1YearInstant5706000000JPY
Noncurrent liabilitiesCurrentQuarterInstant5489000000JPY
LiabilitiesPrior1YearInstant71678000000JPY
LiabilitiesCurrentQuarterInstant60368000000JPY
Capital stockPrior1YearInstant18942000000JPY
Capital stockCurrentQuarterInstant18942000000JPY
Capital surplusPrior1YearInstant13613000000JPY
Capital surplusCurrentQuarterInstant13613000000JPY
Retained earningsPrior1YearInstant172393000000JPY
Retained earningsCurrentQuarterInstant172073000000JPY
Treasury stockPrior1YearInstant-8261000000JPY
Treasury stockCurrentQuarterInstant-2110000000JPY
Shareholders equityPrior1YearInstant196688000000JPY
Shareholders equityCurrentQuarterInstant202518000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant8304000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant8286000000JPY
Foreign currency translation adjustmentPrior1YearInstant898000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant2060000000JPY
Remeasurements of defined benefit plansPrior1YearInstant21000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant366000000JPY
Valuation and translation adjustmentsPrior1YearInstant9223000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant10713000000JPY
Non controlling interestsPrior1YearInstant2097000000JPY
Non controlling interestsCurrentQuarterInstant3008000000JPY
Net assetsPrior1YearInstant208009000000JPY
Net assetsCurrentQuarterInstant216240000000JPY
Liabilities and net assetsPrior1YearInstant279687000000JPY
Liabilities and net assetsCurrentQuarterInstant276608000000JPY
Net salesPrior1YTDDuration141337000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass